Pernix Therapeutics Holdings Inc (PTXTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -34,452 | -32,744 | 11,231 | 10,600 |
| Depreciation Amortization | N/A | 1,683 | 20,534 | 18,935 | 13,040 |
| Accounts receivable | N/A | 1,693 | -1,667 | -5,922 | N/A |
| Other Working Capital | -3,509 | -657 | -5,931 | -11,619 | 860 |
| Other Operating Activity | -1,044 | 36,585 | 46,377 | 11,842 | 6,090 |
| Operating Cash Flow | $-4,553 | $4,852 | $26,569 | $24,467 | $30,590 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 20,021 | 138,950 | -3,590 | -15,371 | 0 |
| Other Investing Activity | 4,226 | 7,371 | 1,045 | 881 | -201,500 |
| Investing Cash Flow | $24,247 | $146,321 | $-2,545 | $-14,490 | $-201,500 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -26,466 | -129,281 | 1,664 | 2,451 | N/A |
| Common Stock Issued | N/A | 4 | 21 | 42 | N/A |
| Common Stock Repurchased | N/A | N/A | -2,425 | -2,478 | N/A |
| Dividend Paid | N/A | -9,889 | -22,131 | -24,302 | -16,330 |
| Other Financing Activity | 0 | -1,703 | -600 | 16,324 | 174,160 |
| Financing Cash Flow | $-26,466 | $-140,869 | $-23,471 | $-7,963 | $157,830 |
| Beginning Cash Position | 14,762 | 4,458 | 3,905 | 1,891 | 14,960 |
| End Cash Position | 7,990 | 14,762 | 4,458 | 3,905 | 1,890 |
| Net Cash Flow | $-6,772 | $10,304 | $553 | $2,014 | $-13,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,553 | 4,852 | 26,569 | 24,467 | 30,590 |
| Capital Expenditure | -2,123 | -1,700 | -3,590 | -15,371 | N/A |
| Free Cash Flow | -6,676 | 3,152 | 22,979 | 9,096 | 30,590 |